ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Aventis Pharmaceuticals


Include trials that are no longer recruiting patients.

13 studies were found.
1.RecruitingBreast Cancer Trial of an Investigational Drug versus Capecitabine in Male or Female Patients with Advanced Breast Cancer
Conditions: Breast Cancer; Metastases
2.RecruitingCompare blood sugar level between Lantus in the morning and other insulins in Type 1 diabetes adolescents
Condition: Diabetes Mellitus
3.RecruitingDetermine whether glycemic control is different between Lantus & a 3rd oral agent when failure with other treatment
Condition: Diabetes Mellitus
4.RecruitingEnoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)
Conditions: Myocardial Infarction; Acute ST-segment elevation
5.RecruitingEnoxaparin versus Unfractionated Heparin in Subjects Who Present to the Emergency Department with Acute Coronary Syndrome (RESCUE)
Condition: Acute coronary syndrome
6.RecruitingEnoxaparin Versus Unfractionated Heparin in the Prevention of Venous Thromboembolism in Patients Following Acute Ischemic Stroke (PREVAIL)
Condition: Acute ischemic stroke
7.RecruitingExtended Prophylaxis for Venous Thromboembolism (VTE) in Acutely Ill Medical Patients with Prolonged Immobilization (EXCLAIM)
Condition: Venous Thromboembolism
8.RecruitingHP184 in Chronic Spinal Cord Injury Subjects
Condition: Spinal Cord Injury
9.RecruitingAn Investigational Drug in Male or Female Patients with Advanced Breast Cancer who no longer respond to Anthracycline, Taxane and Capecitabine Treatment
Condition: Breast Cancer
10.RecruitingOpen Study of enoxaparin vs. unfractionated heparin in patients with acute coronary syndromes
Conditions: Unstable Angina; Myocardial Infarction; Myocardial Ischemia
11.RecruitingThe ORIGIN Trial (Outcome Reduction with Initial Glargine Intervention)
Condition: Diabetes Mellitus, Non-Insulin-Dependent
12.RecruitingSafety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)
Condition: Percutaneous Coronary Intervention
13.RecruitingStudy of DN101 and Taxotere in Patients with Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act